Jamshid KeynejadCo-founder and Managing Director
Prior to forming SK Capital, Mr. Keynejad led a number of private investments in a variety of industries both as a principal investor and managing director. Mr. Keynejad’s investments included leading the acquisition and substantial growth of Signet Diagnostic Imaging Services Group, a divestiture from Cardinal Health that was subsequently sold to a private equity firm. Mr. Keynejad began his career at Ernst & Whinney.
He currently serves as a member of the Board of Directors of Seqens, SI Group and Ascend Performance Materials. He previously served as the Chairman of the Board of IBA Molecular and was a member of the Board of Directors of Halo Pharmaceutical, AEB Group, Addivant, Aristech Acrylics and Perimeter Solutions.
Mr. Keynejad received his B.S.E. in mathematics from London University with first class honors.